🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Integrated solutions for bispecific antibodies - our seamless approach optimizes your experience, delivering high-quality bulk drug substances under accelerated timelines. Learn more: hubs.la/Q02R3P860

Meet Brooke Morgan, Sr. Graphic and Web Designer at KBI Biopharma. Since joining the team, Brooke has been working to elevate the KBI brand. Her role requires collaboration across many functions within the organization and the JSR Life Sciences Network. #KBIBiopharma

At KBI Biopharma, we are committed to continuously improving our processes in support of our customers and their patients around the globe. Learn how we're using technology and the expertise of our scientific teams to speed up process development. hubs.la/Q02SbVf_0

How can we better protect temperature-sensitive biotherapeutics? Solving the challenge of better-stabilized temperature-sensitive biomolecules hinges on innovative formulation strategies. Learn more in this new article by BioPharm International: hubs.la/Q02T9YsP0

Meet Olivia Fagbola (Liv), Payroll Supervisor at our Venture Center facility in Durham, NC. Liv has been a payroll extraordinaire (and self-proclaimed “loud one in the group”) at KBI Biopharma for almost 5 years and describes her team as, “very diverse and spunky!”

SUREmAb offers streamlined cell line development optimized for monoclonal antibodies. Built on the SUREtechnology Platform, SUREmAb takes you from transfection to research cell bank (RCB) in as little as 9 weeks. Learn more: hubs.la/Q02cy7CS0

Our fully-integrated development platform encompasses a strong understanding and efficient production of bispecific antibodies from cell line development (CLD) through to GMP commercial manufacturing. Learn more: hubs.la/Q02cy7BW0

Meet Lindsey, Stability/Sample Coordinator at our Hamlin Road facility who recently celebrated 14 years at KBI Biopharma! Another reason to celebrate, after surgery, chemotherapy, radiation and immunotherapy for breast cancer, she was deemed in remission and cancer free in 2023!

Today’s Team Member Tuesday is Logan Behlke, Associate Director of Downstream Manufacturing at our Hamlin Road facility in Durham, North Carolina. #KBIBiopharma #TeamMemberTuesday

Please join us today in expressing sincere gratitude to the many brave servicemembers that have served in the US Military, including those that now work at KBI Biopharma and within the JSR Life Sciences Network. #VeteransDay2024 #Gratitude #KBIBiopharma

Our bispecific expression combines best-in-class CLD with unmatched expertise and experience in development and manufacturing. We prioritize quality, efficiencies, and time savings in bsAb production across a diverse portfolio of molecule formats. hubs.la/Q02Z6GJ70

Meet Grace McCall (she/her), Senior Research Associate at our Louisville, Colorado facility who has been with KBI Biopharma for four years! Grace uses a variety of biophysical techniques to characterize a range of protein products and presents the results to our customers.

As we celebrate #Thanksgiving today, we want to express our gratitude to all our #KBIBiopharma and JSR Life Sciences colleagues across the globe. Your hard work, dedication, passion, and teamwork drive our success and positively impact countless lives around the world. Thank you!

We are excited to announce that Julie Stiff has been appointed as Senior VP and Site Head at KBI Biopharma’s Boulder, Colorado facility. Please join us in congratulating Julie on this well-deserved appointment!

KBI Biopharma today announced collaboration with Alanis Therapeutics for the development of an innovative pre-clinical therapeutic antibody to treat MDS and AML blood cancers. Read about it here: hubs.la/Q02-3sjs0 #KBIBiopharma #CDMO #AlanisTherapeutics

At KBI Biopharma, we've mastered the art and science of bispecific (monoclonal) antibody development. Our seamless approach optimizes your experience, delivering high-quality bulk drug substances under accelerated timelines. Learn more: hubs.la/Q02cy70B0

From all of us at KBI Biopharma, we wish you a warm and joyful holiday season and a bright start to the New Year. We are grateful for the partnerships, collaborations, and accomplishments that have made 2024 remarkable. Happy Holidays! #KBIBiopharma

From all of us at KBI Biopharma, we wish you a happy, healthy, and prosperous 2025. Cheers to another year of meaningful collaboration, a shared commitment to advancing science, and delivering therapies that positively impact lives around the globe! #HappyNewYear #KBIBiopharma

Are you curious to know how KBI Biopharma is driving breakthroughs in biopharmaceutical development? See for yourself by joining us INSIDE with BioAlps on Tuesday, 21 January at our Geneva facility! The event is free to attend and you can register here: hubs.la/Q031Tjlk0

SUREmAb offers streamlined cell line development for therapeutic mAbs. Our decades of experience have enabled us to design an optimal CLD workflow for secure, speedy development for your program. Learn more: hubs.la/Q02ZyGbL0